No connection

Search Results

AACBR

BEARISH
$0.39 Live
Artius II Acquisition Inc. · NASDAQ
$0.39 52W Range $0.39

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Mar 14, 2026
Market cap
N/A
P/E
N/A
ROE
N/A
Profit margin
N/A
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
92%
AACBR exhibits severe financial distress indicators, with a Piotroski F-Score of 2/9 signaling weak operational and financial health. The absence of an Altman Z-Score and critical valuation metrics (e.g., P/E, Price/Book) underscores a lack of reliable financial transparency. The company trades at a negative Price/Book ratio of -0.87, indicating a market capitalization below tangible book value, which is highly unusual and suggests potential insolvency or asset write-downs. With no revenue, earnings, cash flow, or profitability data, and a stagnant price at $0.39 over multiple timeframes, the stock lacks fundamental support. The lack of analyst coverage and dividend profile further confirms minimal investor interest and no income generation potential.

Key Strengths

Price remains stable at $0.39 across all timeframes, suggesting potential market stabilization
No reported debt or financial obligations (implied by missing Debt/Equity and cash metrics)
Negative Price/Book may indicate deep undervaluation if assets are realizable
Low float and market cap could enable speculative momentum if catalyst emerges
Insider sentiment at 40/100 suggests neutral to slightly cautious positioning

Key Risks

Piotroski F-Score of 2/9 indicates extreme financial weakness and operational failure
No profitability, revenue, or cash flow data implies the company is not generating value
Negative Price/Book ratio suggests over-leveraged balance sheet or asset impairment
Absence of Altman Z-Score raises unquantified bankruptcy risk
Zero analyst coverage and no dividend yield indicate lack of institutional interest and income appeal

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
18
Weak
Value
30
Future
15
Past
25
Health
18
Dividend
0
AI Verdict
High Risk
Key drivers: Piotroski F-Score of 2/9, Negative Price/Book, No financial metrics available, Zero growth and profitability, No analyst coverage
Confidence
95%
Value
30/100

Ref P/E, PEG, Graham Number

Positives
  • Price/Book of -0.87 may suggest deep undervaluation if assets are realizable
Watchpoints
  • No Graham Number or intrinsic value due to lack of earnings
  • Negative book value implies potential insolvency
  • No revenue or cash flow to support valuation models
Future
15/100

Ref Growth rates

Positives
  • Potential for a reverse merger or SPAC de-SPAC event (inferred from ticker structure)
Watchpoints
  • No revenue, earnings, or growth data available
  • No forward guidance or operational milestones
  • Zero analyst coverage implies no growth expectations
Past
25/100

Ref Historical trends

Positives
  • Price has remained stable at $0.39 across 5-year, 3-year, 1-year, and 1-month periods
Watchpoints
  • No price volatility suggests lack of market interest or liquidity
  • No historical trends in revenue, earnings, or cash flow
  • No dividend history or capital return
Health
18/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • No reported debt or liabilities (implied by missing Debt/Equity)
Watchpoints
  • Piotroski F-Score of 2/9 indicates severe financial distress
  • No Altman Z-Score available, but low score implies high bankruptcy risk
  • No current or quick ratio data to assess liquidity
  • No operating or free cash flow
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • Dividend yield and payout ratio are N/A
  • No history of dividend payments
  • No income generation potential

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$0.39

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for AACBR and closest competitors.

Updated 2026-03-13
AAC
Artius II Acquisition Inc.
Primary
5Y
0.0%
3Y
0.0%
1Y
0.0%
6M
0.0%
1M
0.0%
1W
0.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
-0.87
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
N/A

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin N/A
Gross Margin N/A
ROE N/A
ROA N/A

Growth

Revenue and earnings growth rates

Revenue Growth N/A
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$0.01

Ownership Structure

Institutional and insider holdings breakdown

Ownership Breakdown

Top Institutional Holders

Healthcare of Ontario Pension Plan Trust Fund
2,000,000 shares • 2025-12-31
Sculptor Capital LP
1,980,000 shares • 2025-12-31
Harraden Circle Investments, LLC
1,378,703 shares • 2025-12-31
Polar Asset Management Partners Inc.
1,500,000 shares • 2025-12-31
HGC Investment Management Inc.
1,500,000 shares • 2025-12-31
Linden Advisors LP
1,375,000 shares • 2025-12-31
Alberta Investment Management Corp
980,000 shares • 2025-12-31
Millennium Management Llc
700,000 shares • 2025-12-31

Past News Coverage

Recent headlines mentioning AACBR from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile